CVS · CVS HEALTH Corp · Proposed Sales
$82.89
-2.92 (-3.40%)
At close · Nov 18
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$109.79B
Shares
1.28B
Volume · Nov 18
5.29M
Avg daily vol (3M)
9.11M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-05-22 | AGUIRRE FERNANDO | Director | 2,263 | 2026-05-20 | TD Securities (USA) LLC |
| 2026-05-21 | FARAH ROGER N | Director | 2,817 | 2026-05-21 | Charles Schwab Corp. |
| 2026-05-08 | TILAK MANDADI | Officer | 69,551 | 2026-05-08 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-08-19 | Finucane Anne A. | Director | 7,500 | 2025-08-20 | Merrill Lynch, Pierce, Fenner & Smith Incorporated |
| 2025-03-05 | Clark James David | Officer | 7,513 | 2025-03-05 | MORGAN STANLEY SMITH BARNEY LLC, EXECUTIVE SERVICES |
| 2024-02-16 | PREM S SHAH | Officer | 29,473 | 2024-02-16 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2023-08-03 | Clark James David | Officer | 25,759 | 2023-08-03 | ETRADE FINANCIAL CORPORATION |
Showing 1–7 of 7 filings
Key facts
CIK
64803
CUSIP
126650100
13F (30d)
1823 filings
1708 filers
Visit website
Investor relations